FDMDF
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | -0.31 | $3M | -$13M |
| 2025 Q4 | -0.05 | $3M | -$20M |
| 2024 Q2 | -0.03 | $3M | -$14M |
| 2024 Q4 | -0.07 | $3M | -$16M |
| 2023 Q2 | -0.04 | $792,505 | -$15M |
| 2023 Q4 | -0.05 | $232,713 | -$18M |
| 2022 Q2 | -0.05 | $485,868 | -$6M |
| 2022 Q4 | -0.04 | $897,689 | -$8M |